Case Report
Metastatic Prostate Adenocarcinoma Presenting Central Diabetes Insipidus
Table 1
Baseline and after treatment endocrinological and biochemical evaluation.
| | First | After treatment | Normal range |
| Serum | | | | TSH | 0.60 | 0.85 | 0.4–5.5 microIU/mL | Free T4 | 1.28 | 1.31 | 0.74–1.52 ng/dL | Free T3 | 2.4 | 2.6 | 2.3–4.2 pg/mL | FSH | 5.3 | 4.1 | 1.9–18.9 IU/L | LH | 0.7 | 0.8 | 1.7–9.6 IU/L | Total testosterone | 18 | 14 | 370–1000 ng/dL | Prolactin | 5.8 | 12.1 | 2.7–18.3 ng/mL | IGF-1 | 98 | 100 | 84–238 ng/mL | ACTH | 14.2 | 15.1 | 7–46 pg/mL | Basal cortisol | 18.3 | 18.4 | 4.6–22.80 μg/dL | Sodium | 151 | 137 | 132–146 mEq/L | Calcium | 9.2 | 9.1 | 8.6–10.2 mg/dL | Creatinine | 0.79 | 0.78 | 0.7–1.3 mg/dL | Potassium | 5 | 4.6 | 3.5–5.5 mEq/L | Urea | 26 | 28 | 19–48 mg/dL | Albumin | 4.1 | 3.9 | 3.2–4.8 mg/dL | Osmolality | 315 | 292 | 285–300 | Urine | | | | Volume (1 day) | 9.2 | 2.1 | lt | Specific gravity | 1.001 | 1.018 | 1.010–1.020 | Osmolality (mosm/kg) | 78 | 450 | 300–1090 mosm/kg |
|
|